Tetrahydrobiopterin-dependent Production of L-DOPA in Genetically Modified Primary Fibroblasts: Basic Research of Gene Therapy for Parkinson's Disease
Although intracerebral transplantation might become a new strategy for the treatment of neurological diseases, there are many problems for the grafts, We examined the possibilities of primary skin fibroblasts as a new graft for Parkinson's disease. Rat primary skin fibroblasts were transfected...
Gespeichert in:
Veröffentlicht in: | Pteridines 1996-11, Vol.7 (4), p.151-153 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Although intracerebral transplantation might become a new strategy for the treatment of neurological diseases, there are many problems for the grafts, We examined the possibilities of primary skin fibroblasts as a new graft for Parkinson's disease. Rat primary skin fibroblasts were transfected with a retrovirus vector containing eDNA of human tyrosine hydroxylast typel (TH) (pLTHSNL) or cytomegalovirus promoter (pCTHSNL) as a foreign promoter. In these genetically modified fibroblasts, catecholamine production and release were analyzed in vitro by immunocytochemistry and high performance liquid chromatography with electrochemical detection (HPLC-ECD), Being supplemented with biopterin (BH
; (6R)-L-erythro-tetrahydrobiopterin) cofactors required for TH activity, these cells produced and released L-DOPA into the culture medium. When combined with a foreign promoter and BH
, L-DOPA production increased in a timedependent manner, which was not affected by the number of cell-passages and the duration of liquid nitrogen freezing . These facts suggest that the amount of L-DOPA secreted from transplanted genetically modified fibroblasts can be manipulated by an inserted promoter the exogenously administered BH
. Thus genetically modified primary skin fibroblasts transfected with THcDNA using retrovirus vector system may hold promise as a graft for transplantation and gene therapy for Parkinson's disease. |
---|---|
ISSN: | 0933-4807 2195-4720 |
DOI: | 10.1515/pteridines.1996.7.4.151 |